Parkinson’s Disease

Metals associated neurodegeneration in Parkinson’s disease: Insight to physiological, pathological mechanisms and management

 There is increasing evidence that heavy metals normally present in the human body in minute concentration also cause accumulation to initiate the free radical formation and affecting the basal ganglia signaling. In this review, we explored how these metals affect brain physiology and their roles in the accumulation of toxic proteins (α-synuclein and Lewy bodies). […]

Metals associated neurodegeneration in Parkinson’s disease: Insight to physiological, pathological mechanisms and management Read More »

Complications following REM sleep behavior disorder

REM sleep behavior disorder (RBD) is gaining increasing attention as important prodromal marker for the development of neurodegenerative disorders such as Parkinson’s Disease. However, the clinical relevance of this disorder and its association with other prodromal markers is often underestimated in clinical routine. We here report a case of severe clinical complications following extensive nocturnal

Complications following REM sleep behavior disorder Read More »

Fibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease

Hence, autophagy modulation might provide some interesting cues for the treatment of PD. Additionally, Fibroblast growth factor 21 (FGF21) which is known for its role as a potent regulator of glucose and energy metabolism has also proved to be neuroprotective in various neurodegenerative conditions possibly via mediation of autophagy. CLICK TO REVIEW

Fibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease Read More »

Natural antioxidants in the management of Parkinson’s disease: review of evidence from cell line and animal models

Therefore, the use of natural antioxidants in PD may provide an alternative therapy that prevents oxidative stress and reduces disease progression. In this review, the effects of hydroxytyrosol, Ginkgo biloba, Withania somnifera, curcumin, green tea, and Hypericum perforatum in PD animal and cell line models are compared and discussed. The reviewed antioxidants show evidence of protecting neural cells from

Natural antioxidants in the management of Parkinson’s disease: review of evidence from cell line and animal models Read More »

Is Chelation Therapy a Potential Treatment for Parkinson’s Disease

The current use of chelators in clinical medicine is presented together with a discussion of two clinical trials of PD patients where an iron chelator was administered and showed encouraging results. It is proposed that the use of anti-inflammatory drugs combined with an iron chelator might be a better approach to increase chelator efficacy. CLICK

Is Chelation Therapy a Potential Treatment for Parkinson’s Disease Read More »

Effects of α-Synuclein-Associated Post-Translational Modifications in Parkinson’s Disease

In this Review, we summarize the structure and physiological function of α-syn, and we further highlight the major PTMs (namely phosphorylation, ubiquitination, nitration, acetylation, truncation, SUMOylation, and O-GlcNAcylation) of α-syn and the effects of these modifications on α-syn aggregation, which may elucidate mechanisms for PD pathogenesis and lay a theoretical foundation for clinical treatment of

Effects of α-Synuclein-Associated Post-Translational Modifications in Parkinson’s Disease Read More »

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease

Bile acid analysis in the PD appendix reveals an increase in hydrophobic and secondary bile acids, deoxycholic acid (DCA) and lithocholic acid (LCA). Further proteomic and transcriptomic analysis in the appendix and ileum corroborated these findings, highlighting changes in the PD gut that are consistent with a disruption in bile acid control, including alterations in

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease Read More »

Identification of novel biomarkers for Parkinson’s disease by metabolomic technologies

Metabolomic analysis detected biomarkers associated with PD pathogenesis and disease progression. Since critical metabolic biomarkers need to be identified in PD, future studies should include assay validation and replication in independent cohorts. CLICK TO REVIEW

Identification of novel biomarkers for Parkinson’s disease by metabolomic technologies Read More »